Neurotherapeutics. 2026 Jul 10;23(4):e00963. doi: 10.1016/j.neurot.2026.e00963. Online ahead of print.ABSTRACTPatients with established cardiovascular disease (CVD) may have a higher risk of recurrent stroke and a higher prevalence of antiplatelet resistance than those without CVD. This study investigated the efficacy and safety of dual antiplatelet therapy (DAPT) with clopidogrel plus aspirin in patients with established CVD. This is a secondary post…